Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis
- 1 November 2001
- Vol. 56 (11) , 1077-1080
- https://doi.org/10.1034/j.1398-9995.2001.00082.x
Abstract
Nasal congestion is among the most bothersome of the symptoms of intermittent allergic rhinitis (IAR). Decongestants such as pseudoephedrine are often accompanied by adverse effects and should be avo...Keywords
This publication has 14 references indexed in Scilit:
- Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H1-Receptor Antagonist, in Patients with Seasonal Allergic RhinitisClinical Drug Investigation, 2001
- Once‐daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double‐blind, placebo‐controlled studyInternational Journal of Dermatology, 2001
- Allergic Rhinitis: Epidemiology and Natural HistoryAllergy and Asthma Proceedings, 2000
- Cognitive, Social, and Economic Costs of Allergic RhinitisAllergy and Asthma Proceedings, 2000
- 1130 Desloratadine and erythromycin: Pharmacokinetics and electrocardiographic pharmacodynamic effectsJournal of Allergy and Clinical Immunology, 2000
- 49 Anti-inflammatory properties of desloratadine (DCL): Effect on eosinophil chemotaxis, adhesion and release of superoxide anionsJournal of Allergy and Clinical Immunology, 2000
- National guidelines needed to manage rhinitis and prevent complicationsAnnals of Allergy, Asthma & Immunology, 1999
- Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and ImmunologyAnnals of Allergy, Asthma & Immunology, 1998
- Nasal obstruction as a risk factor for sleep-disordered breathingJournal of Allergy and Clinical Immunology, 1997
- Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 1995